Annual EBITDA
-$2.86B$897.00M+23.88%
Summary
- Current Value
- As of today, MRNA annual EBITDA is -$2.86B, up +23.88% on
- Historical Performance
- MRNA annual EBITDA is down -129.74% over the past 3 years, down -290.63% over the past 5 years
- All-Time High Comparison
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on
- 3-Year Low Comparison
- MRNA annual EBITDA is +23.88% above its 3-year low of -$3.76B reached on
- Sector Comparison
- MRNA annual EBITDA is higher than 0.17% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$2.86B | +23.9% | -129.7% | -290.6% | -10000.0% | |
| Quarterly EBITDA | -$790.00M | +33.4% | -149.4% | -195.5% | -10000.0% | |
| TTM EBITDA | -$2.86B | +23.9% | -129.7% | -290.6% | -10000.0% | |
| Price | $51.37 | +54.4% | -63.1% | -65.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.94B | -39.9% | -89.8% | +142.0% | +10000.0% | |
| Annual EPS | -$7.25 | +21.8% | -136.1% | -270.3% | +99.8% | |
| $0.00 | +100.0% | -100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$2.82B | +20.8% | -133.8% | -277.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.61B | N/A | -129.7% |
| 5Y | $13.47B | -121.2% | |
| All | $13.47B | -121.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.76B | +23.9% | |
| 5Y | -$3.76B | +23.9% | |
| All | -$3.76B | +23.9% |
EBITDA History
FAQ
What is the current annual EBITDA of MRNA?
As of today, MRNA annual EBITDA is -$2.86B
What is 1-year change in MRNA annual EBITDA?
MRNA annual EBITDA is up +23.88% year-over-year
What is 3-year change in MRNA annual EBITDA?
MRNA annual EBITDA is down -129.74% over the past 3 years
How far is MRNA annual EBITDA from its all-time high?
MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on December 31, 2021
How does MRNA annual EBITDA rank versus sector peers?
MRNA annual EBITDA is higher than 0.17% of companies in Healthcare sector
When is MRNA next annual earnings release?
As of today, the next annual earnings release for MRNA has not been scheduled
Quarterly EBITDA
-$790.00M$582.00M-279.81%
Summary
- Current Value
- As of today, MRNA quarterly EBITDA is -$790.00M, down -279.81% on
- Historical Performance
- MRNA quarterly EBITDA is up +33.39% year-over-year, down -149.38% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBITDA is currently -114.58% below its historical high of $5.42B set on
- 3-Year Low Comparison
- MRNA quarterly EBITDA is +55.54% above its 3-year low of -$1.78B reached on
- Sector Comparison
- MRNA quarterly EBITDA is higher than 0.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$790.00M | -279.8% | +33.4% | -149.4% | -195.5% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| TTM EBITDA | -$2.86B | +12.2% | +23.9% | -129.7% | -290.6% | |
| Price | $51.37 | +107.6% | +54.4% | -63.1% | -65.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $678.00M | -33.3% | -29.8% | -86.5% | +18.8% | |
| Quarterly EPS | -$2.11 | -310.9% | +27.6% | -158.3% | -206.8% | |
| -$857.00M | -229.6% | +31.2% | -156.4% | -211.6% | ||
| Quarterly Net Income | -$826.00M | -313.0% | +26.3% | -156.4% | -203.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$208.00M | -279.8% | |
| 3Y | $1.60B | N/A | -149.4% |
| 5Y | $5.42B | -114.6% | |
| All | $5.42B | -114.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.19B | N/A | +33.4% |
| 3Y | -$1.78B | +55.5% | |
| 5Y | -$1.78B | +55.5% | |
| All | -$1.78B | +55.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MRNA?
As of today, MRNA quarterly EBITDA is -$790.00M
What is MRNA quarterly EBITDA most recent change?
MRNA quarterly EBITDA was down -279.81% on December 31, 2025
What is 1-year change in MRNA quarterly EBITDA?
MRNA quarterly EBITDA is up +33.39% year-over-year
How far is MRNA quarterly EBITDA from its all-time high?
MRNA quarterly EBITDA is currently -114.58% below its historical high of $5.42B set on December 31, 2021
How does MRNA quarterly EBITDA rank versus sector peers?
MRNA quarterly EBITDA is higher than 0.27% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM EBITDA
-$2.86B$396.00M+12.17%
Summary
- Current Value
- As of today, MRNA TTM EBITDA is -$2.86B, up +12.17% on
- Historical Performance
- MRNA TTM EBITDA is up +23.88% year-over-year, down -129.74% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBITDA is currently -117.36% below its historical high of $16.47B set on
- 3-Year Low Comparison
- MRNA TTM EBITDA is +37.44% above its 3-year low of -$4.57B reached on
- Sector Comparison
- MRNA TTM EBITDA is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$2.86B | +12.2% | +23.9% | -129.7% | -290.6% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| Quarterly EBITDA | -$790.00M | -279.8% | +33.4% | -149.4% | -195.5% | |
| Price | $51.37 | +107.6% | +54.4% | -63.1% | -65.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.94B | -12.9% | -39.9% | -89.8% | +142.0% | |
| TTM EPS | -$7.26 | +9.9% | +21.8% | -136.3% | -274.8% | |
| -$3.07B | +11.2% | +22.1% | -133.2% | -302.8% | ||
| TTM Net Income | -$2.82B | +9.4% | +20.8% | -133.8% | -277.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.86B | at high | |
| 3Y | $9.61B | N/A | -129.7% |
| 5Y | $16.47B | -117.4% | |
| All | $16.47B | -117.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.76B | N/A | +23.9% |
| 3Y | -$4.57B | +37.4% | |
| 5Y | -$4.57B | +37.4% | |
| All | -$4.57B | +37.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MRNA?
As of today, MRNA TTM EBITDA is -$2.86B
What is MRNA TTM EBITDA most recent change?
MRNA TTM EBITDA was up +12.17% on December 31, 2025
What is 1-year change in MRNA TTM EBITDA?
MRNA TTM EBITDA is up +23.88% year-over-year
How far is MRNA TTM EBITDA from its all-time high?
MRNA TTM EBITDA is currently -117.36% below its historical high of $16.47B set on March 31, 2022
How does MRNA TTM EBITDA rank versus sector peers?
MRNA TTM EBITDA is higher than 0.18% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna